关于
  • English
  • About
    • About Sirona
    • Management
    • Board of Directors
    • Strategic Advisory Board
    • Our Partners
  • TFChem
    • About TFChem
    • Management
    • Team
    • TFChem Laboratory Capabilities
  • Programs
    • Proprietary Platform Technology
    • Pipeline
    • Diabetes – SGLT2 Inhibitor
    • Skincare – Dark Spot Correction
    • Skincare – Anti-Aging / Anti-Wrinkle
    • Antiviral
  • News
    • Sirona News
    • Events
  • Investors
    • Financial Information
    • Financial Reports
    • Investor & Media Kit
    • Newsletter
  • Contact
  • Careers

Investor & Media Kit

COMPANY DOCUMENTS & VIDEOS
  • SBM Investor Presentation - December 2022 (EN)
  • SBM Investor Presentation - June 2022 (FR)
  • SBM Interview with CEO & CSO - November 2021
  • SBM Interview on cafepharma - May 2021
  • VIDEO – How our Technology Works (Animation)
COMPANY DOCUMENTS IN CHINESE
  • SBM Investor Presentation – Chinese
  • SBM Corporate One Pager – May 2018 
  • SBM Dermatology One Pager – May 2018
  • Sirona TFChem – 1067 Description
  • Sirona TFChem – 1165 Description
  • Sirona TFChem – LIP-01 Description
NEWS ARTICLES & REPORTS
  • Sirona Biochem Featured on Fierce Biotech - November 2022
  • Sirona Biochem Featured on Investing News Network (INN) - since January 2020
  • Dose of the Valley – February 2016
  • Times Colonist – Four biotech companies that are helping B.C. lead the battle against aging – March 2015
  • Dose of the Valley – February 2015
  • Sirona Biochem Featured on Stockhouse – TickerTrax, January 2, 2015
  • National Post Article – Rich source of innovation: Biotech community makes Canada a key player on the world stage, February 6, 2014
  • Bottom Line Report featuring Sirona Biochem by Biotech Analyst Katherine Austin – March 2013
  • BioPharmInsight Article – Sirona in active discussions to out-license SGLT, December 14, 2012
  • Feature – TFChem, INPI Winner, Story of TFChem in cartoon format (French) – November 2012
  • Business in Vancouver How I Did It by Howard Verrico – July 2012
  • Noverra Watch List Report by Steve Lux, January 31, 2012
  • Article – Cantech Letter Interviews Howard Verrico, CEO of Sirona Biochem
  • Article – BIO Business, Sirona Biochem Tackling Twin Epidemics
SELECTED SCIENTIFIC JOURNALS
  • Journal – Synthetic Carbohydrate-Based Anticancer Vaccines
  • Journal – Nature Reviews, SGLT Inhibition, A Novel Strategy for Diabetes Treatment
  • Journal – Trends in Pharmaceutical Sciences, SGLT
  • Journal – International Journal of Pharma Sciences and Research
  • About
  • TFChem
  • Programs
  • News
  • Investors
  • Contact

© 2023 Sirona Biochem.

Sirona Biochem Corp
c/o WeWork
595 Burrard St.
Vancouver, B.C., Canada,V7X 1L4

TFCHEM
Voie de l’innovation
Pharma Parc II Chaussée du Vexin
27100 Val de Reuil, France

General inquires: 604.641.4466
Investor inquiries (Momentum PR): 450.332.6939
info@sironabiochem.com

© 2023 Sirona Biochem.

Sirona Biochem Corp
c/o WeWork
595 Burrard St.
Vancouver, B.C., Canada,V7X 1L4

TFCHEM
Voie de l’innovation
Pharma Parc II Chaussée du Vexin
27100 Val de Reuil, France

General inquires: 604.641.4466
Investor inquiries (Momentum PR): 450.332.6939
info@sironabiochem.com

Enter your info below to subscribe to our newsletter:
Loading